Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTP ICAP Regulatory News (TCAP)

Share Price Information for TP ICAP (TCAP)

Share Price is delayed by 15 minutes
Get Live Data
344.60    0.20 (0.06%)
Bid:
343.60
Ask:
344.80
Spread: 1.20 (0.349%)
Market Cap: £2.52b
TCAP Live PriceLast checked at - London Stock Exchange

Intraday TP ICAP Share Chart

Acquisition

16 Sep 2019 16:13

RNS Number : 5023M
TP ICAP PLC
16 September 2019
 

16 September 2019

 

TP ICAP acquires ClearCompress

Expansion into innovative compression services

 

TP ICAP plc ("TP ICAP" or "the Company") today announces that it has acquired ClearCompress Limited ("ClearCompress"), a provider of innovative, algorithm-based, light-touch compression services in cleared and uncleared derivatives that assist clients to achieve cost efficiencies and capital reduction.

 

TP ICAP and ClearCompress started collaborating in 2017. At that time, ClearCompress contributed development and algorithm expertise and TP ICAP contributed access to clients and support infrastructure. The parties deepened their relationship in March 2019 when TP ICAP agreed to provide funding of £500,000 and the benefit of its regulated status to ClearCompress. The parties have now agreed to formalise their relationship with the acquisition of ClearCompress by TP ICAP. The key team members of ClearCompress, including David Hill, the CEO, will remain with the business and continue to expand its client base and service range.

 

The sellers of ClearCompress are the founders, early-stage investors and management team. The consideration for the acquisition is £750,000 in cash to be paid over 2 years, and performance-related payments for the 6 years starting 1 September 2019 until 31 August 2025 based on the revenues of the business, payable annually in cash or shares at the discretion of TP ICAP.

 

The gross assets of ClearCompress at 31 January 2019 were £88,152 and the business reported a loss before tax of £346,606 for the year ended 31 January 2019.

 

Nicolas Breteau, CEO of TP ICAP, said, "The acquisition of ClearCompress is in line with our strategy to broaden our customer service offering. The compression runs we have conducted demonstrate excellent outcomes for our clients. We are delighted to welcome this innovative company with its expertise in algo-driven capital optimisation solutions to our group and we are excited to move forward and grow the business together."

 

David Hill, CEO of ClearCompress, said, "As ClearCompress enters the next phase in its development, we are looking forward to being a part of the TP ICAP Group which will enable us to accelerate our client reach, develop new products and expand internationally. Our partnership with TP ICAP and the solutions we deliver have been well received by clients and we are enthusiastic and confident about what more we can do in the future."

 

ENDS

 

Enquiries:

 

TP ICAP:

Analysts and Investors

Al Alevizakos

Alevizos.Alevizakos@tpicap.com

+44 (0) 203 933 3040

 

Media

William Baldwin-Charles

William.Baldwin-Charles@tpicap.com 

+44 (0) 20 7200 7124

 

About TPICAP

TP ICAP brings together buyers and sellers in global financial, energy and commodities markets. It is the world's largest wholesale market intermediary, with a portfolio of businesses that provide broking services, data & analytics and market intelligence, trusted by clients around the world. We operate from offices in 31 countries, supporting award-winning brokers with market-leading technology.

www.tpicap.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ACQCKADDPBKDBCD
Date   Source Headline
5th Jan 20172:13 pmRNSHolding(s) in Company
4th Jan 201711:38 amRNSHolding(s) in Company
3rd Jan 20175:51 pmRNSTotal Voting Rights
30th Dec 20168:05 amRNSAdmission of new shares
30th Dec 20167:00 amRNSCompletion of transaction with NEX
28th Dec 201611:07 amRNSChange of Name
28th Dec 20167:00 amRNSStatement re transaction with NEX
9th Dec 20167:00 amRNSDividend Declaration
6th Dec 20161:40 pmRNSStatement re transaction with ICAP
1st Dec 201610:02 amRNSHolding(s) in Company
23rd Nov 201611:29 amRNSHolding(s) in Company
15th Nov 201612:09 pmRNSStatement re transaction with ICAP
4th Nov 20167:00 amRNSTrading Statement
1st Nov 201612:52 pmRNSDirector Declaration
3rd Oct 20162:34 pmRNSTP ICAP Global Executive Committee
3rd Oct 20162:29 pmRNSTullett Prebon Management Changes
3rd Oct 20169:55 amRNSTotal Voting Rights
27th Sep 20162:15 pmRNSAdditional Listing
26th Sep 20167:03 amRNSStatement re transaction with ICAP
12th Sep 20163:49 pmRNSPublication of Supplementary Prospectus
8th Sep 201612:20 pmRNSStatement on transaction with Tullett Prebon
8th Sep 201612:15 pmRNSStatement re transaction with ICAP
24th Aug 20162:15 pmRNSHolding(s) in Company
3rd Aug 20162:15 pmRNSDirector/PDMR Shareholding
2nd Aug 20169:08 amRNSNew Technology Centre, Belfast Northern Ireland
2nd Aug 20167:00 amRNSHalf-year Report
22nd Jul 20161:15 pmRNSStatement re transaction with ICAP
29th Jun 20166:00 pmRNSNotification of Interim Results
21st Jun 20166:25 pmRNSStatement re transaction with ICAP
20th Jun 201610:21 amRNSHolding(s) in Company
7th Jun 20167:09 amRNSStatement re. CMA announcement
6th Jun 20164:18 pmRNSHolding(s) in Company
16th May 201612:08 pmRNSPublication of Supplementary Prospectus
16th May 20167:13 amRNSIGBB FY 2016 results
13th May 201612:16 pmRNSDirectorate Change
13th May 201610:17 amRNSResult of AGM
12th May 20167:00 amRNSTrading Statement
6th May 20167:00 amRNSDirectorate Change
5th May 20164:41 pmRNSDirector/PDMR Shareholding
4th May 201612:51 pmRNSHolding(s) in Company
22nd Apr 20165:18 pmRNSDirector/PDMR Shareholding
19th Apr 20165:27 pmRNSDirector/PDMR Shareholding
5th Apr 20162:49 pmRNSPublication of Supplementary Prospectus
4th Apr 20164:48 pmRNSAnnual Financial Report
24th Mar 20162:16 pmRNSEGM Statement
1st Mar 201611:37 amRNSPublication of Prospectus
1st Mar 20167:00 amRNSStatement re acquisition
1st Mar 20167:00 amRNSFinal Results
5th Feb 20168:00 amRNSAdoption of Financial Reporting Standard (FRS)101
2nd Feb 20167:00 amRNSStatement re acquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.